Effect of Cyclooxygenase Activity on Amyloid

About the Research Project
Program
Award Type
Standard
Award Amount
$500,000
Active Dates
August 01, 2004 - July 31, 2007
Grant ID
A2004517
Summary
This study focuses on the effects of an enzyme, cyclo-oxygenase, on amyloid beta, the protein fragment that aggregates into plaques in the brains of Alzheimer’s patients. The process by which amyloid beta accumulates and clumps together to create plaques is not well understood, but scientists think it is central to the development of Alzheimer’s disease. The study may shed light on how non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin and ibuprofen are thought to lower the risk of developing Alzheimer’s disease. NSAIDs are known to inhibit the actions of cyclo-oxygenases, and the scientists believe that if they can succeed in creating a more powerful compound to block cyclo-oxygenase activity, it could lead to a drug that would actually halt the disease. Current Alzheimer’s drugs treat the symptoms, but no drug has been found yet to stop the progression of Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Shining a Light on How Early Tau-Related Brain Changes Affect Memory Loss
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Martin Dahl, PhD
Alzheimer's Disease Research
The Role of Immune Cells’ Interaction in Alzheimer’s Disease Pathology
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Emanuela Pasciuto, PhD